AU2002332507A1 - Levothyroxine compositions and methods - Google Patents

Levothyroxine compositions and methods

Info

Publication number
AU2002332507A1
AU2002332507A1 AU2002332507A AU2002332507A AU2002332507A1 AU 2002332507 A1 AU2002332507 A1 AU 2002332507A1 AU 2002332507 A AU2002332507 A AU 2002332507A AU 2002332507 A AU2002332507 A AU 2002332507A AU 2002332507 A1 AU2002332507 A1 AU 2002332507A1
Authority
AU
Australia
Prior art keywords
methods
levothyroxine compositions
levothyroxine
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002332507A
Inventor
Phillip A. Dimenna
G. Andrew Franz
Rocco L. Gemma
Elaine A. Strauss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
King Pharmaceuticals Inc
Original Assignee
King Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Inc filed Critical King Pharmaceuticals Inc
Publication of AU2002332507A1 publication Critical patent/AU2002332507A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
AU2002332507A 2001-08-10 2002-08-10 Levothyroxine compositions and methods Abandoned AU2002332507A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US31152401P 2001-08-10 2001-08-10
US31155201P 2001-08-10 2001-08-10
US31152201P 2001-08-10 2001-08-10
US31152301P 2001-08-10 2001-08-10
US31154901P 2001-08-10 2001-08-10
US60/311,524 2001-08-10
US60/311,549 2001-08-10
US60/311,523 2001-08-10
US60/311,522 2001-08-10
US60/311,552 2001-08-10
PCT/US2002/025475 WO2003013441A2 (en) 2001-08-10 2002-08-10 Levothyroxine compositions and methods

Publications (1)

Publication Number Publication Date
AU2002332507A1 true AU2002332507A1 (en) 2003-02-24

Family

ID=27540960

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002332507A Abandoned AU2002332507A1 (en) 2001-08-10 2002-08-10 Levothyroxine compositions and methods

Country Status (2)

Country Link
AU (1) AU2002332507A1 (en)
WO (1) WO2003013441A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645526B2 (en) 2001-11-13 2003-11-11 Mylan Pharmaceuticals, Inc. Storage stable thyroxine active drug formulations and methods for their production
US20030099699A1 (en) 2001-11-13 2003-05-29 Hanshew Dwight D. Storage stable thyroxine active drug formulations and methods for their production
US20060141054A1 (en) * 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
CN115078576B (en) * 2022-06-14 2024-02-13 陕西九州制药有限责任公司 Analytical method for related substances of paracetamol and dihydrocodeine tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401892D0 (en) * 1994-02-01 1994-03-30 Boots Co Plc Therapeutic agents
EP0861073B1 (en) * 1995-11-14 2004-07-28 Abbott GmbH & Co. KG Stabilized thyroid hormone preparations and methods of making same
WO1999063969A1 (en) * 1998-06-08 1999-12-16 Groenewoud Pieter J Stabilized thyroxine medications

Also Published As

Publication number Publication date
WO2003013441A3 (en) 2003-10-30
WO2003013441A2 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002241114A1 (en) Composition
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods
AUPR446801A0 (en) Novel compositions and uses therefor
AU2002366809A1 (en) Syn3 compositions and methods
AU2002332507A1 (en) Levothyroxine compositions and methods
AU2003268078A1 (en) Levothyroxine compositions and methods
AU2002359869A1 (en) Pak5-related compositions and methods
AU2002362468A1 (en) Levothyroxine compositions and methods
AU2002246221A1 (en) Method and composition
AU2002331660A1 (en) Supported fluridone compositions and methods
AUPR369201A0 (en) Compositions and uses therefor - i
AUPR369101A0 (en) Compositions and uses therefor - iv
AUPR369001A0 (en) Compositions and uses therefor - iii
AUPR368901A0 (en) Compositions and uses therefor-ii
AU2002307237A1 (en) Carboxybenzopyran derivatives and compositions
AUPR114600A0 (en) Novel compositions and uses therefor
AUPQ723100A0 (en) Compositions and uses therefor - I
AUPQ723400A0 (en) Compositions and uses therefor - IV
AUPQ723300A0 (en) Compositions and uses therefor - III
AUPQ723200A0 (en) Compositions and uses therefor - II

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase